Invested in Navidence, a clinical-trial and real-world-evidence data platform for life sciences companies serving Merck, AstraZeneca, and Novo Nordisk.
Navidence provides the RWE Sherpa platform with professional services to enable RWE researchers to define their study element definitions and navigate towards the right fit-4-purpose data sources to the underlying research need, unlocking the power of health data for patients and the wider healthcare community
Navidence provides the RWE Sherpa platform with professional services to enable RWE researchers to define their study element definitions and navigate towards the right fit-4-purpose data sources to the underlying research need, unlocking the power of health data for patients and the wider healthcare community.